Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age

Elevated serum levels of neuron-specific enolase (NSE) was initially assumed to be specific to neuronal tumors (particularly neuroblastoma), but is now known to accompany nontumoral conditions and tumors other than neuroblastomas. There is a need to establish normal ranges for NSE, especially in ear...

Full description

Bibliographic Details
Main Authors: Aslihan Abbasoglu, Faik Sarialioglu, Nalan Yazici, Nilufer Bayraktar, Aysegul Haberal, Ayse Erbay
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:Pediatrics and Neonatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957214001375
id doaj-c7a23af3a97d4342af5d95740e0799df
record_format Article
spelling doaj-c7a23af3a97d4342af5d95740e0799df2020-11-24T22:23:54ZengElsevierPediatrics and Neonatology1875-95722015-04-0156211411910.1016/j.pedneo.2014.07.005Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of AgeAslihan Abbasoglu0Faik Sarialioglu1Nalan Yazici2Nilufer Bayraktar3Aysegul Haberal4Ayse Erbay5Division of Neonatology, Department of Pediatrics, Baskent University Faculty of Medicine, Ankara, TurkeyDivision of Pediatric Oncology, Department of Pediatrics, Baskent University Faculty of Medicine, Ankara, TurkeyDivision of Pediatric Oncology, Department of Pediatrics, Baskent University Faculty of Medicine, Adana, TurkeyDepartment of Biochemistry, Baskent University Faculty of Medicine, Ankara, TurkeyDepartment of Biochemistry, Baskent University Faculty of Medicine, Ankara, TurkeyDivision of Pediatric Oncology, Department of Pediatrics, Baskent University Faculty of Medicine, Adana, TurkeyElevated serum levels of neuron-specific enolase (NSE) was initially assumed to be specific to neuronal tumors (particularly neuroblastoma), but is now known to accompany nontumoral conditions and tumors other than neuroblastomas. There is a need to establish normal ranges for NSE, especially in early infancy. The aims of this study were to determine reference values for NSE in newborns and young infants and to assess whether NSE levels in early infancy (i.e., preterm infants and term infants) differ from the adult reference range for this enzyme. Methods: We enrolled 140 healthy babies, which included 40 preterm newborns (3–15 days old and born at 28–42 weeks gestation), 40 term newborns (< 1 month old and born at term), and 60 young infants 1–3 months old (n = 20 per subgroup of 1-, 2-, and 3-month-old infants). The determination of NSE levels was performed by the electrochemiluminescence immunoassay (ECLIA) method using the Elecysys 2010 device (Roche Diagnostics, Mannheim, Germany). The mean serum NSE levels for the preterm newborns was 21.83 ± 15.06 ng/mL [95% confidence interval (95%CI), 16.95–26.71 ng/mL]; term newborns, 18.06 ± 12.83 ng/mL (95%CI, 13.94–22.19 ng/mL); and young infants, 9.09 ± 4.38 ng/mL (95%CI, 7.96–10.23 ng/mL). The mean serum NSE level for infants 1–3 months old was within the ECLIA kit's normal range (4.7–18 ng/mL for adults), whereas the corresponding means for the preterm and term newborns were higher (p < 0.001, for both). Conclusion: Our findings suggest that adult reference values should not be applied to the preterm and term age groups.http://www.sciencedirect.com/science/article/pii/S1875957214001375infantneuron-specific enolasereference values
collection DOAJ
language English
format Article
sources DOAJ
author Aslihan Abbasoglu
Faik Sarialioglu
Nalan Yazici
Nilufer Bayraktar
Aysegul Haberal
Ayse Erbay
spellingShingle Aslihan Abbasoglu
Faik Sarialioglu
Nalan Yazici
Nilufer Bayraktar
Aysegul Haberal
Ayse Erbay
Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
Pediatrics and Neonatology
infant
neuron-specific enolase
reference values
author_facet Aslihan Abbasoglu
Faik Sarialioglu
Nalan Yazici
Nilufer Bayraktar
Aysegul Haberal
Ayse Erbay
author_sort Aslihan Abbasoglu
title Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
title_short Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
title_full Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
title_fullStr Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
title_full_unstemmed Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
title_sort serum neuron-specific enolase levels in preterm and term newborns and in infants 1–3 months of age
publisher Elsevier
series Pediatrics and Neonatology
issn 1875-9572
publishDate 2015-04-01
description Elevated serum levels of neuron-specific enolase (NSE) was initially assumed to be specific to neuronal tumors (particularly neuroblastoma), but is now known to accompany nontumoral conditions and tumors other than neuroblastomas. There is a need to establish normal ranges for NSE, especially in early infancy. The aims of this study were to determine reference values for NSE in newborns and young infants and to assess whether NSE levels in early infancy (i.e., preterm infants and term infants) differ from the adult reference range for this enzyme. Methods: We enrolled 140 healthy babies, which included 40 preterm newborns (3–15 days old and born at 28–42 weeks gestation), 40 term newborns (< 1 month old and born at term), and 60 young infants 1–3 months old (n = 20 per subgroup of 1-, 2-, and 3-month-old infants). The determination of NSE levels was performed by the electrochemiluminescence immunoassay (ECLIA) method using the Elecysys 2010 device (Roche Diagnostics, Mannheim, Germany). The mean serum NSE levels for the preterm newborns was 21.83 ± 15.06 ng/mL [95% confidence interval (95%CI), 16.95–26.71 ng/mL]; term newborns, 18.06 ± 12.83 ng/mL (95%CI, 13.94–22.19 ng/mL); and young infants, 9.09 ± 4.38 ng/mL (95%CI, 7.96–10.23 ng/mL). The mean serum NSE level for infants 1–3 months old was within the ECLIA kit's normal range (4.7–18 ng/mL for adults), whereas the corresponding means for the preterm and term newborns were higher (p < 0.001, for both). Conclusion: Our findings suggest that adult reference values should not be applied to the preterm and term age groups.
topic infant
neuron-specific enolase
reference values
url http://www.sciencedirect.com/science/article/pii/S1875957214001375
work_keys_str_mv AT aslihanabbasoglu serumneuronspecificenolaselevelsinpretermandtermnewbornsandininfants13monthsofage
AT faiksarialioglu serumneuronspecificenolaselevelsinpretermandtermnewbornsandininfants13monthsofage
AT nalanyazici serumneuronspecificenolaselevelsinpretermandtermnewbornsandininfants13monthsofage
AT niluferbayraktar serumneuronspecificenolaselevelsinpretermandtermnewbornsandininfants13monthsofage
AT aysegulhaberal serumneuronspecificenolaselevelsinpretermandtermnewbornsandininfants13monthsofage
AT ayseerbay serumneuronspecificenolaselevelsinpretermandtermnewbornsandininfants13monthsofage
_version_ 1725763338253631488